Scope Of Practice: Pharmacist Perspectives On Plaque Psoriasis

11 Questions | Total Attempts: 117

SettingsSettingsSettings
Please wait...
Scope Of Practice: Pharmacist Perspectives On Plaque Psoriasis

Test Your Knowledge of Plaque Psoriasis


Questions and Answers
  • 1. 
    What is the prevalence of psoriasis in the general population?
    • A. 

      2%

    • B. 

      5%

    • C. 

      7%

    • D. 

      10%

  • 2. 
    The two main age ranges for initial onset and diagnosis of psoriasis are:
    • A. 

      Early teens and again in the 70s

    • B. 

      Late teens to early adulthood and again in the 70s

    • C. 

      Late teens to early adulthood and again in the late 50s to early 60s

    • D. 

      Late 30s and again in the late 50s to early 60s

  • 3. 
    Psoriasis is not a risk factor for cardiovascular disease.
    • A. 

      True

    • B. 

      False

  • 4. 
    Psoriasis patients do not have an increased risk of inflammatory disease and depression.
    • A. 

      True

    • B. 

      False

  • 5. 
    The central theme of the Canadian Guidelines for the Management of Plaque Psoriasis is that physicians (prescribers) should not only choose therapies that work, but those that the patient will work with.
    • A. 

      True

    • B. 

      False

  • 6. 
    One fingertip unit of psoriasis topical cream, ointment or gel is equal to:
    • A. 

      1 g of cream/ointment/gel, covering an area the size of one side of the patient’s hand

    • B. 

      0.5 g of cream/ointment/gel, covering an area the size of one side of the patient’s hand

    • C. 

      1 g of cream/ointment/gel, covering an area the size of two sides of the patient’s hand

    • D. 

      0.5 g of cream/ointment/gel, covering an area the size of two sides of the patient’s hand

  • 7. 
    Mixing of bases or adding ingredients may reduce the potency and shelf-life of some formulations.
    • A. 

      True

    • B. 

      False

  • 8. 
    Side effects of topical corticosteroids include skin atrophy, stretch marks, and/or adrenal gland suppression.
    • A. 

      True

    • B. 

      False

  • 9. 
    In calcipotriol/betamethasone diproprionate therapy, marked improvement or clearance is generally seen:
    • A. 

      Within 2 weeks

    • B. 

      Within 3 weeks

    • C. 

      Within 4 weeks

    • D. 

      After 6 weeks

  • 10. 
    Which of the following is not a potential trigger for psoriasis:
    • A. 

      Warm weather

    • B. 

      Alcohol consumption

    • C. 

      Streptococcal infection

    • D. 

      Emotional stress

  • 11. 
    Most provinces have expanded scope of practice and reimbursed pharmacist services which can be integrated to improve the quality of life for the psoriatic patient.
    • A. 

      True

    • B. 

      False

Back to Top Back to top